From the cinchona dispute to the hydroxychloroquine dispute, or how our drug protection system is being tested: A historical, scientific and legal analysis
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | From the cinchona dispute to the hydroxychloroquine dispute, or how our drug protection system is being tested: A historical, scientific and legal analysis |
Type de publication | Journal Article |
Year of Publication | 2020 |
Auteurs | Guerriaud M |
Journal | MEDECINE & DROIT |
Pagination | 96-101 |
Date Published | AUG |
Type of Article | Article |
ISSN | 1246-7391 |
Mots-clés | Covid-19 (drugs), Pharmacist (liability), Prescription (drugs), Temporary recommendation for use (drugs) |
Résumé | The current dispute over the use of hydroxychloroquine in coronavirus disease 2019 (covid-19) resonates with another dispute, that of cinchona, which took place in the 17th Century. This historical aside is a reminder that scientific disputes have always existed, so it is not surprising that the properties of hydroxychloroquine are subject to controversy. However, the facts are the facts: its effectiveness is doubtful, while the risks are certain. That is why in France the Prime Minister has chosen to regulate its prescription by decree. But this decree, although surely the only possible option, raises many problems. (C) 2020 Elsevier Masson SAS. All rights reserved. |
DOI | 10.1016/j.meddro.2020.05.003 |